Literature DB >> 11701098

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer.

S Ward1, E Morris, N Bansback, N Calvert, A Crellin, D Forman, M Larvin, D Radstone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11701098     DOI： 10.3310/hta5240

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN： 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  6 in total

Review 1.  Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical Review.

Authors:  Mahdi Gharaibeh; J Lyle Bootman; Ali McBride; Jennifer Martin; Ivo Abraham
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

Review 2.  Pancreatic cancer.

Authors:  Hemant M Kocher; Wasfi Alrawashdeh
Journal:  BMJ Clin Evid       Date:  2010-05-19

3.  The encapsulation of the gemcitabine anticancer drug into grapheme nest: a theoretical study.

Authors:  Marwa Mlaouah; Bahoueddine Tangour; Mohammed El Khalifi; Tijani Gharbi; Fabien Picaud
Journal:  J Mol Model       Date:  2018-03-22       Impact factor: 1.810

4.  Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.

Authors:  Jose G Trevino; Justin M Summy; Donald P Lesslie; Nila U Parikh; David S Hong; Francis Y Lee; Nicholas J Donato; James L Abbruzzese; Cheryl H Baker; Gary E Gallick
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 5.  Vitamin D for the prevention and treatment of pancreatic cancer.

Authors:  Kun-Chun Chiang; Tai C Chen
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

6.  Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy.

Authors:  Andrei Maksimenko; Mouad Alami; Fatima Zouhiri; Jean-Daniel Brion; Alain Pruvost; Julie Mougin; Abdallah Hamze; Tanguy Boissenot; Olivier Provot; Didier Desmaële; Patrick Couvreur
Journal:  ACS Nano       Date:  2014-02-26       Impact factor: 15.881
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.